Patient Health Questionnaire

Mental Health Outcomes Demonstrate the Swift and Significant Impact of TimelyCare

Retrieved on: 
Wednesday, May 1, 2024
Education, Risk, PHQ-9, LMFT, Depression, Grammatical mood, Patient Health Questionnaire, Attention, Patient safety, Senior counsel, Psychiatry, GPA, Mental health, Movement, Faculty, GAD-7, MBC, Evidence-based practice, Student, Nursing

FORT WORTH, Texas, May 1, 2024 /PRNewswire/ -- TimelyCare, higher education's most trusted virtual health and well-being provider, is swiftly and significantly improving the mental health of those who need support the most. This is highly important given mental health is the #1 reason students drop out of college.

Key Points: 
  • This is highly important given mental health is the #1 reason students drop out of college.
  • TimelyCare began using Measurement-Based Care (MBC) last year, an evidence-based practice of tracking patient-reported progress in real-time to enhance treatment outcomes.
  • TimelyCare practitioners started collecting Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder Assessment (GAD-7) scores prior to Scheduled Counseling and Psychiatry visits.
  • "The TimelyCare MBC data underscore the correlation between improved mental health outcomes and student success," said Bob Booth, M.D., TimelyCare's Chief Care Officer.

GrayMatters Health Announces Pioneering Study Highlighting Safety and Efficacy of Self-Neuromodulation for PTSD

Retrieved on: 
Tuesday, February 6, 2024
PTSD, Checklist, Research, Magnetic resonance, Psychiatry, Patient, Safety, FDA, GMH, NYU Langone Health, EFP, Computer simulation, Patient Health Questionnaire, Entrepreneurship, Psychotherapy, Mental health, DSM-5, Journal, EEG, Health, Woman

HAIFA, Israel and NEW YORK, Feb. 6, 2024 /PRNewswire/ -- GrayMatters Health (GMH), developer of digital self-neuromodulation therapies for mental health care, announces the publication of a peer-reviewed article in the Journal of Psychiatry Research demonstrating the safety and efficacy of its FDA-cleared Prism for PTSD device. The prospective, single arm, multi-site, open label trial evaluated men, women, and treatment-resistant combat veterans with chronic post-traumatic stress disorder (PTSD).

Key Points: 
  • The prospective, single arm, multi-site, open label trial evaluated men, women, and treatment-resistant combat veterans with chronic post-traumatic stress disorder (PTSD).
  • Prism for PTSD is the first self-neuromodulation device to receive FDA clearance as a prescribed adjunct to standard-of-care for PTSD.
  • The treatment, now available in select clinics in the United States, digitizes brain activity associated with PTSD to scientifically help patients gain control of their PTSD symptoms.
  • Prism for PTSD uses a computer simulation and EEG headset to create a novel, immersive environment for training individuals to self-modulate an amygdala-based biomarker associated with PTSD.

Hedonia: Novel Approach Finds Dramatic Improvement in Depression Scores in Robust Clinical Trial

Retrieved on: 
Wednesday, December 13, 2023
Software, Other Health, General Health, Telemedicine, Virtual Medicine, Biometrics, Mental Health, Apps, Applications, Technology, Medical Devices, Health Technology, Clinical Trials, Biotechnology, Health, Patient Health Questionnaire, Motivation, Waze, Depression, Research, MGH, Randomized controlled trial, Hippocampus, Patient, Samuel, Psychiatry, Anxiety, FTP, MADRS, DSM-IV codes, MD, Harvard Medical School, Diagnosis, Massachusetts General Hospital, Doctor of Philosophy, Mental health, Hospital, Pharmaceutical industry, Nursing, Medical device

This is the first study to use a therapeutic app based on Facilitating Thought ProgressionTM (FTP), a novel approach to mood disorders that disrupts cyclical, repetitive patterns of rigid thinking common in depression and anxiety.

Key Points: 
  • This is the first study to use a therapeutic app based on Facilitating Thought ProgressionTM (FTP), a novel approach to mood disorders that disrupts cyclical, repetitive patterns of rigid thinking common in depression and anxiety.
  • All participants continued their ongoing conventional treatment (medication, therapy, or both), if they were already on any, during the study.
  • On the Montgomery-Asberg Depression Rating Scale (MADRS), a clinician-administered assessment, the depression severity scores of participants in the intervention group dropped by 43%, while the control group’s scores dropped by 18%.
  • The researchers emphasized that this is the first study to examine the delivery of FTP using a mobile application.

Holmusk's NeuroBlu Database Reaches Pivotal Milestone of 4 Million Patient Lives

Retrieved on: 
Thursday, November 16, 2023
Research, Patient Health Questionnaire, Natural language processing, Gold, Data, Patient, NLP, Mental status examination, Mental health, MSE, Health, Drug development

NEW YORK, Nov. 16, 2023 /PRNewswire/ -- Holmusk, a leading global behavioral health real-world evidence company, today announced that NeuroBlu has reached a major growth milestone of over 4 million patient lives, making it the largest structured real-world database purpose-built for behavioral health.

Key Points: 
  • The NeuroBlu Database is now the largest NLP-enriched, de-identified real-world data platform designed for behavioral and mental health
    NEW YORK, Nov. 16, 2023 /PRNewswire/ -- Holmusk, a leading global behavioral health real-world evidence company, today announced that NeuroBlu has reached a major growth milestone of over 4 million patient lives, making it the largest structured real-world database purpose-built for behavioral health.
  • With the addition of 2.5 million new patient lives, the NeuroBlu data analytics platform has more than doubled in size and boosted its representation of the U.S. patient population, and now includes patients in all 50 states across more than 1 million providers.
  • Holmusk works with its partners to continually integrate new data to optimize the depth and breadth of data in the NeuroBlu Database.
  • The data within NeuroBlu is critical to Holmusk's goal of closing the evidence gap in behavioral health to support drug development, clinical research, patient access and positively impact patient outcomes.

First Randomized Controlled Trial Comparing Woebot to Clinician-Led Psychotherapy Reveals Digital Mental Health Intervention Is Non-Inferior in Reducing Depressive Symptoms Among Teens

Retrieved on: 
Thursday, October 26, 2023
Mental Health, Health, Consumer, Apps, Applications, Technology, Teens, Cognitive behavioral therapy, Adolescence, Triage, Mental, Clinical trial, MD, Journal of the American Academy of Child and Adolescent Psychiatry, Doctor of Philosophy, Research, CHKD, Multimedia, Pediatrics, Union, White, American Academy, AACAP, Eastern Virginia Medical School, African Americans, CBT, Safety, Depression, Anxiety, Bentham Science Publishers, Patient, Grammatical mood, Patient Health Questionnaire, Mental health, Nursing, Child

The results were presented in a poster presentation at the American Academy of Child and Adolescent Psychiatry ( AACAP ) conference.

Key Points: 
  • The results were presented in a poster presentation at the American Academy of Child and Adolescent Psychiatry ( AACAP ) conference.
  • View the full release here: https://www.businesswire.com/news/home/20231026083262/en/
    This is the first known study to compare an agent-based digital mental health intervention to a therapist-led therapeutic intervention in a real-world clinical setting.
  • The findings suggest a potential role for W-GenZD within outpatient mental health care clinics to address the ongoing adolescent mental health crisis.
  • A non-inferiority test was used to evaluate the study aim comparing the reduction in PHQ-8-measured depression symptoms between the two interventions at the end of treatment.

Magellan Healthcare Releases Clinical White Paper on the Need for Evidence-Based Digital Cognitive Behavioral Therapy Programs

Retrieved on: 
Tuesday, September 19, 2023
General Health, Mental Health, Health, Science, Research, Acceleration, Cognitive behavioral therapy, Depression, Feedback, Anxiety, Health care, Patient Health Questionnaire, PHQ-9, GAD-7, CBT, Magellan Health, Organization, Literature, Digital Emotion, United, Ferdinand Magellan, MPH, United States $1 Coin Act of 1997, Risk management, Nursing

Magellan Healthcare, Inc. , a leader in behavioral healthcare, has released a clinical white paper outlining the positive, real-world impact of evidence-based digital cognitive behavioral therapy (DCBT).

Key Points: 
  • Magellan Healthcare, Inc. , a leader in behavioral healthcare, has released a clinical white paper outlining the positive, real-world impact of evidence-based digital cognitive behavioral therapy (DCBT).
  • Americans who suffer from behavioral health concerns need adaptable technologies that:
    provide on-demand personalized healthcare journeys, and
    offer relevant solutions that engage individuals in their care.
  • In collaboration with NeuroFlow , Magellan launched the enhanced Digital Emotional Wellbeing suite in January 2022 that included its proven digital cognitive behavioral therapy (DCBT) modules FearFighter®, MoodCalmer, SHADE, RESTORE®, and ComfortAble®.
  • True evidence-based DCBT follows the exact cognitive behavioral therapy (CBT) process, differing from evidence-informed digital programs that use some CBT practices, but are not built with fidelity to the model.

Aiberry Introduces AI-Powered Mental Health Assessments for Corporate Wellness Platforms

Retrieved on: 
Tuesday, August 8, 2023
Technology, Mental Health, Other Technology, Health Technology, Software, Internet, Health, General Health, Artificial Intelligence, Linda, Depression, Workplace, Patient Health Questionnaire, PHQ-9, Multimedia, DSM-IV codes, Patient, Diagnosis, Artificial intelligence, AI, Mental health, Nursing, Management

Artificial intelligence (AI)-powered mental health screening pioneer Aiberry (pronounced “I” + “berry”) today announced a new version of the Aiberry platform specifically designed to meet the needs of corporate wellness platform users.

Key Points: 
  • Artificial intelligence (AI)-powered mental health screening pioneer Aiberry (pronounced “I” + “berry”) today announced a new version of the Aiberry platform specifically designed to meet the needs of corporate wellness platform users.
  • New analytics capabilities introduced as part of the Aiberry corporate wellness platform enable corporate wellness program administrators to track utilization of the platform as well as employee wellness over time.
  • (Graphic: Business Wire)
    Aiberry for corporate wellness users comes at a time when the need for mental health programs in the workplace has never been greater.
  • “The expansion of the Aiberry platform into corporate wellness brings the benefits of AI-powered mental health assessment to a critical population, American workers, which is massively underserved by currently-available behavioral health resources,” said Aiberry Co-Founder and Co-CEO Linda Chung.

Lark Health's AI Coaching Drives Weight Loss Results in HPSAs

Retrieved on: 
Thursday, July 13, 2023
International, Education, Telephone numbers in Hungary, Population Health Management, Patient Health Questionnaire, Weight loss, DPP, Genolier Swiss Medical Network SA, Lark, HPSA, Human–computer interaction, HCI, MHealth, Digital health, Collection, Lark Health, Risk, Grammatical mood, Body mass index, Ecosystem, Health, JMIR, Dietary supplement

These studies continue to support Lark's mission to provide clinically proven, digital condition management coaching solutions that address total population health and improve participant health outcomes.

Key Points: 
  • These studies continue to support Lark's mission to provide clinically proven, digital condition management coaching solutions that address total population health and improve participant health outcomes.
  • The study found that member weight loss did not differ by HPSA despite greater potential barriers for this group.
  • The results demonstrated decreases in depressive symptoms, regardless of initial body mass index, and that those who lost weight experienced greater decreases.
  • The study demonstrates how Lark's design team incorporated critical elements of human coaches into the Lark digital coach to ensure that it can develop meaningful and effective coaching relationships with members of the Lark programs.

Solera Health Report Reveals New Insights Into Factors Contributing to Sustained Mental Health Burden Post-Pandemic

Retrieved on: 
Thursday, May 25, 2023
Depression, Anxiety, Mental health, Patient Health Questionnaire, Mental Health Awareness Month, Creativity, Patient, Clutch (eggs), Generalized anxiety disorder, Key finding attacks, Behavior, Nursing, Pharmaceutical industry

Key Findings from the Report:

Key Points: 
  • Key Findings from the Report:
    The burden of mental health symptoms remains extremely high (41.7%) even as the pandemic public health emergency comes to an end.
  • A meaningful portion of Americans (13%) report being bothered by their mental health despite relative low levels of symptoms that do not meet typical screening thresholds.
  • “When it comes to mental health, we know that one size doesn’t fit all,” said Dr. Byron Crowe, Chief Medical Officer at Solera Health.
  • A wide range of questions explored physical health, mental health, treatments and preferences, stigma, lifestyle, attitudes, beliefs and behavior.

National Sleep Foundation Highlights Evidence in General US Population Connecting Sleep Health with Probable Depressive Disorder

Retrieved on: 
Wednesday, May 24, 2023
Clifford Whittingham Beers, National Alliance, National Sleep Foundation, Depression, Sleep, National Alliance on Mental Illness, Bureau of Oceans and International Environmental and Scientific Affairs, Patient Health Questionnaire, NSF, Public, American Psychological Association, APA, PHQ-9, Doctor of Philosophy, Bangladesh Technical Education Board, CDC, Organization, DSM-IV codes, MD, Mental disorder, Korea Disease Control and Prevention Agency, NAMI, Health, Mental health, NIH, Suicide, Pharmaceutical industry, Nursing, Research

WASHINGTON, May 24, 2023 /PRNewswire/ -- Today, the National Sleep Foundation (NSF) highlighted additional findings from its 2023 Sleep in America® Poll, which previously demonstrated meaningful connections between Americans' sleep health and their mental health and wellness. Among key findings were that nearly 1 in 5 (19%) US adults who sleep less than the NSF-recommended 7-9 hours per night meet criteria for a probable clinical diagnosis of a depressive disorder.

Key Points: 
  • WASHINGTON, May 24, 2023 /PRNewswire/ -- Today, the National Sleep Foundation (NSF) highlighted additional findings from its 2023 Sleep in America® Poll, which previously demonstrated meaningful connections between Americans' sleep health and their mental health and wellness.
  • Nearly 1 in 5 US adults who sleep less than 7-9 hours per night meet criteria for a probable depressive disorder.
  • Released during the 25th anniversary of NSF's Sleep Awareness Week®, this year's poll uniquely co-administered three NSF sleep health assessments—Sleep Health Index®, Sleep Satisfaction Tool®, and Best Slept Self® Questionnaire—along with the Patient Health Questionnaire-9 (PHQ-9), an established measure of symptoms of depression.
  • "These results go beyond just alerting people that sleep health and mental health are linked," said David Neubauer, MD, a practicing psychiatrist and member of National Sleep Foundation's Board of Directors.